{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:05:36Z","timestamp":1779919536060,"version":"3.53.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:00Z","timestamp":1597449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s10067-020-05265-3","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:06:19Z","timestamp":1597485979000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Utilization of acute gout prophylaxis in the real world: a retrospective database cohort analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Marina L.","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Saseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza W.","family":"Claus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,15]]},"reference":[{"issue":"11","key":"5265_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649\u2013662. https:\/\/doi.org\/10.1038\/nrrheum.2015.91","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"5265_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1080\/15257770802136032","volume":"27","author":"MA Becker","year":"2008","unstructured":"Becker MA, MacDonald PH, Hunt BJ et al (2008) Determinants of the clinical outcomes of gout during the first year of urate-lowering therapy. Nucleosides Nucleotides Nucleic Acids 27(6):585\u2013591. https:\/\/doi.org\/10.1080\/15257770802136032","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"3","key":"5265_CR3","first-page":"33","volume":"42","author":"JA Tilleman","year":"2017","unstructured":"Tilleman JA, Desimone EM II, McAuliffe R (2017) Urate-lowering therapy for prevention and treatment of gout flare. US Pharm 42(3):33\u201337","journal-title":"US Pharm"},{"issue":"10","key":"5265_CR4","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"W Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, Gerster J, Jacobs J, Leeb B, Liot\u00e9 F, McCarthy G, Netter P, Nuki G, Perez-Ruiz F, Pignone A, Piment\u00e3o J, Punzi L, Roddy E, Uhlig T, Zimmermann-G\u00f2rska I, EULAR Standing Committee for International Clinical Studies Including Therapeutics (2006) EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65(10):1312\u20131324","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"5265_CR5","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/acr.21773","volume":"64","author":"D Khanna","year":"2012","unstructured":"Khanna D, Khanna PP, Fitzgerald JD, Singh MK, Bae S, Neogi T, Pillinger MH, Merill J, Lee S, Prakash S, Kaldas M, Gogia M, Perez-Ruiz F, Taylor W, Liot\u00e9 F, Choi H, Singh JA, Dalbeth N, Kaplan S, Niyyar V, Jones D, Yarows SA, Roessler B, Kerr G, King C, Levy G, Furst DE, Edwards NL, Mandell B, Schumacher HR, Robbins M, Wenger N, Terkeltaub R, American College of Rheumatology (2012) American College of Rheumatology guidelines for management of gout. Part II: therapy and anti-inflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res 64(10):1447\u20131461. https:\/\/doi.org\/10.1002\/acr.21773","journal-title":"Arthritis Care Res"},{"issue":"1","key":"5265_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Liot\u00e9 F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209707","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5265_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M16-0570","volume":"166","author":"A Qaseem","year":"2017","unstructured":"Qaseem A, Harris RP, Forciea MA, for the Clinical Guidelines Committee of the American College of Physician (2017) Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med 166(1):58\u201368. https:\/\/doi.org\/10.7326\/M16-0570","journal-title":"Ann Intern Med"},{"key":"5265_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/annrheumdis-2013-203325","volume":"73","author":"F Sivera","year":"2014","unstructured":"Sivera F, Andres M, Carmona L et al (2014) Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 73:328\u2013335","journal-title":"Ann Rheum Dis"},{"key":"5265_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/rheumatology\/kem056a","volume":"46","author":"KM Jordan","year":"2007","unstructured":"Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G, British Society for Rheumatology and British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group (SGAWG) (2007) British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 46:1372\u20131374","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5265_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/BOR.0000000000000154","volume":"27","author":"PP Khanna","year":"2015","unstructured":"Khanna PP, Fitzgerald J (2015) Evolution of management of gout: a comparison of recent guidelines. Curr Opin Rheumatol 27(2):139\u2013146. https:\/\/doi.org\/10.1097\/BOR.0000000000000154","journal-title":"Curr Opin Rheumatol"},{"key":"5265_CR11","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1093\/rheumatology\/ket158","volume":"52","author":"LR Harrold","year":"2013","unstructured":"Harrold LR, Mazor KM, Negron A, Ogarek J, Firneno C, Yood RA (2013) Primary care providers\u2019 knowledge, beliefs and treatment practices for gout: results of a physician questionnaire. Rheumatology (Oxford) 52:1623\u20131629. https:\/\/doi.org\/10.1093\/rheumatology\/ket158","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"5265_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3899\/jrheum.080487","volume":"36","author":"EQ Wu","year":"2009","unstructured":"Wu EQ, Patel PA, Mody RR et al (2009) Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol 36(5):1032\u20131040. https:\/\/doi.org\/10.3899\/jrheum.080487","journal-title":"J Rheumatol"},{"issue":"2","key":"5265_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","volume":"12","author":"CA Sarawate","year":"2006","unstructured":"Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW (2006) Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol 12(2):61\u201365","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"5265_CR14","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1093\/rheumatology\/kes183","volume":"51","author":"JJ Saseen","year":"2012","unstructured":"Saseen JJ, Agashivala N, Allen RR, Ghushchyan V, Yadao AM, Nair KV (2012) Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford) 51(11):2004\u20132012. https:\/\/doi.org\/10.1093\/rheumatology\/kes183","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"5265_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/14397595.2017.1318467","volume":"28","author":"J Yu","year":"2018","unstructured":"Yu J, Qiu Q, Liang L, Yang X, Xu H (2018) Prophylaxis of acute flares when initiating febuxostat for chronic gouty arthritis in a real-world clinical setting. Mod Rheumatol 28(2):339\u2013344. https:\/\/doi.org\/10.1080\/14397595.2017.1318467","journal-title":"Mod Rheumatol"},{"issue":"1","key":"5265_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s100670050005","volume":"19","author":"B Pal","year":"2000","unstructured":"Pal B, Foxall M, Dysart T, Carey F, Whittaker M (2000) How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 19(1):21\u201325. https:\/\/doi.org\/10.1007\/s100670050005","journal-title":"Clin Rheumatol"},{"issue":"12","key":"5265_CR17","first-page":"2429","volume":"31","author":"GC Borstad","year":"2004","unstructured":"Borstad GC, Bryant LR, Abel MP, Scroggie DA, Harris MD, Alloway JA (2004) Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. J Rheumatol 31(12):2429\u20132432","journal-title":"J Rheumatol"},{"issue":"2","key":"5265_CR18","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1186\/ar2659","volume":"11","author":"LR Harrold","year":"2009","unstructured":"Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, Ockene IS (2009) Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 11(2):R46. https:\/\/doi.org\/10.1186\/ar2659","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5265_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3899\/jrheum.140588","volume":"42","author":"N Rashid","year":"2015","unstructured":"Rashid N, Coburn BW, Wu Y et al (2015) Modifiable factors associated with allopurinol adherence outcomes among gout patients in an integrated health system. J Rheumatol 42(3):504\u2013512. https:\/\/doi.org\/10.3899\/jrheum.140588","journal-title":"J Rheumatol"},{"issue":"7","key":"5265_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/ijcp.12604","volume":"69","author":"S Mantarro","year":"2015","unstructured":"Mantarro S, Capogrosso-Sansone A, Tuccori M, Blandizzi C, Montagnani S, Convertino I, Antonioli L, Fornai M, Cricelli I, Pecchioli S, Cricelli C, Lapi F (2015) Allopurinol adherence among patients with gout: an Italian general practice database study. Int J Clin Pract 69(7):757\u2013765. https:\/\/doi.org\/10.1111\/ijcp.12604","journal-title":"Int J Clin Pract"},{"issue":"9","key":"5265_CR21","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","volume":"57","author":"LM Scheepers","year":"2018","unstructured":"Scheepers LM, Burden AM, Arts IW et al (2018) Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD). Rheumatology (Oxford) 57(9):1641\u20131650. https:\/\/doi.org\/10.1093\/rheumatology\/key155","journal-title":"Rheumatology (Oxford)"},{"key":"5265_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/annrheumdis-2012-201676","volume":"72","author":"F Rees","year":"2013","unstructured":"Rees F, Jenkins W, Doherty M (2013) Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study. Ann Rheum Dis 72:826\u2013830. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201676","journal-title":"Ann Rheum Dis"},{"key":"5265_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/annrheumdis-2017-211574","volume":"77","author":"H Yamanaka","year":"2018","unstructured":"Yamanaka H, Tamaki S, Ide Y, Kim H, Inoue K, Sugimoto M, Hidaka Y, Taniguchi A, Fujimori S, Yamamoto T (2018) Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre, randomised study. Ann Rheum Dis 77:270\u2013276","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05265-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05265-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T23:25:17Z","timestamp":1628983517000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05265-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,15]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5265"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05265-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,15]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was submitted to the Colorado Multiple Institutional Review Board (COMIRB) and was determined to be exempt.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The study protocol was submitted to the Colorado Multiple Institutional Review Board (COMIRB) and was determined to be exempt","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}